Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 2003

View Archived Issues

Completion of phase I study of vaccinia immune globulin

Screening commences for phase II study of Prosaptide

Advanced Biotherapy to study antibody therapy in organ transplant rejection

Roche presents novel DPP-IV inhibitors in a recent patent

New HIV protease inhibitors prepared and tested at Tibotec-Virco

Lundbeck claims glycine transport inhibitors and their use in psychosis, cognition disorders, etc.

Novel PDE7 inhibitors and their use reported by Daiichi Suntory and Suntory scientists

HNE inhibitors with potential in COPD therapy covered by Bayer patent

Bayer researchers design adenosine A1 receptor agonists for ischemic disorders

New mGluR1 antagonists in early development at Bayer

Two series of adenosine A3 receptor antagonists described by Sanofi-Synthelabo

Analgesic effects reported for KRN-5500 in a murine model of neuropathic pain

Potential use of interferon in the therapy of SARS

Priority review for diquafosol tetrasodium NDA

Bexxar launched in U.S.

Small-molecule Bcl-2 inhibitor with apoptosis-inducing effects in cancer cells

Cytogen completes reacquisition of Quadramet marketing rights

Evotec Neurosciences and Takeda form Alzheimer's collaboration

Maxim discusses discovery and development of apoptosis inducers at cancer meeting

Enbrel approved to improve physical function in RA patients

FDA approves Zavesca for type 1 Gaucher's disease

Japan Tobacco to commercialize Gilead HIV products in Japan

FDA advisory committee sets review date for Raptiva

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...